When WIRED featured Jennifer Doudna's microbial gene editing project in late 2023, it brought star power to a nascent field. However, a Paris-based biotech has been quietly advancing this research and is set to move into clinical trials next year.
Founded in 2014 as a spin-off from MIT and Rockefeller University, Eligo took a unique approach to CRISPR, focusing on...